DE69425589D1 - Kombiniertes antipyretisches und analgetisches arzneimittel - Google Patents

Kombiniertes antipyretisches und analgetisches arzneimittel

Info

Publication number
DE69425589D1
DE69425589D1 DE69425589T DE69425589T DE69425589D1 DE 69425589 D1 DE69425589 D1 DE 69425589D1 DE 69425589 T DE69425589 T DE 69425589T DE 69425589 T DE69425589 T DE 69425589T DE 69425589 D1 DE69425589 D1 DE 69425589D1
Authority
DE
Germany
Prior art keywords
combined
isopropylantipyrine
antipyretic
layer containing
analgetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69425589T
Other languages
English (en)
Other versions
DE69425589T2 (de
Inventor
Takashi Fujitsu
Kikuko Yoneda
Isao Ikebe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26416787&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69425589(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of DE69425589D1 publication Critical patent/DE69425589D1/de
Application granted granted Critical
Publication of DE69425589T2 publication Critical patent/DE69425589T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69425589T 1993-12-10 1994-12-02 Kombiniertes antipyretisches und analgetisches arzneimittel Expired - Fee Related DE69425589T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP31080393 1993-12-10
JP7563894 1994-04-14
PCT/JP1994/002031 WO1995015751A1 (fr) 1993-12-10 1994-12-02 Medicament a principes actifs combines antipyretique et analgesique

Publications (2)

Publication Number Publication Date
DE69425589D1 true DE69425589D1 (de) 2000-09-21
DE69425589T2 DE69425589T2 (de) 2001-01-04

Family

ID=26416787

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69425589T Expired - Fee Related DE69425589T2 (de) 1993-12-10 1994-12-02 Kombiniertes antipyretisches und analgetisches arzneimittel

Country Status (13)

Country Link
US (1) US5686109A (de)
EP (1) EP0812589B1 (de)
JP (1) JP3168582B2 (de)
KR (1) KR100347631B1 (de)
CN (1) CN1094756C (de)
AT (1) ATE195418T1 (de)
DE (1) DE69425589T2 (de)
DK (1) DK0812589T3 (de)
ES (1) ES2148470T3 (de)
GR (1) GR3034434T3 (de)
PT (1) PT812589E (de)
TW (1) TW279799B (de)
WO (1) WO1995015751A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6348216B1 (en) * 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
US6812985B1 (en) 1996-09-23 2004-11-02 Lg.Philips Lcd Co., Ltd. Liquid crystal display device
KR100251512B1 (ko) 1997-07-12 2000-04-15 구본준 횡전계방식 액정표시장치
JP4828707B2 (ja) * 2000-02-28 2011-11-30 武田薬品工業株式会社 固形圧縮製剤
ATE330586T1 (de) * 2001-03-14 2006-07-15 Pfizer Prod Inc Pharmazeutische tablette und eine verfahren zu deren herstellung
GB0113839D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
JP2003095944A (ja) * 2001-09-27 2003-04-03 Kowa Co 鎮痛剤
JP2006527184A (ja) * 2003-06-06 2006-11-30 エティファーム 口腔内分散性多層錠剤
FR2855756B1 (fr) * 2003-06-06 2005-08-26 Ethypharm Sa Comprime orodispersible multicouche
AU2005292670B2 (en) * 2004-05-21 2011-02-03 Accu-Break Technologies, Inc. Scored pharmaceutical tablets comprising a plurality of segments
EP1948138A4 (de) * 2005-11-18 2012-07-11 Accu Break Technologies Inc Segmentierte pharmazeutische dosierformen
US8202538B2 (en) * 2006-06-26 2012-06-19 Capricorn Pharma, Inc. Orally disintegrating layered compositions
US20110086092A1 (en) * 2006-08-08 2011-04-14 Accu-Break Technologies, Inc. Pharmacuetical tablets containing a plurality of active ingredients
EP2070520A1 (de) 2007-12-11 2009-06-17 LEK Pharmaceuticals D.D. Pharmazeutische Zusammensetzung mit mindestens einem Wirkstoff und einem in einem sauren Medium quellenden Bindemittel
JP2013121948A (ja) * 2011-11-07 2013-06-20 Daiichi Sankyo Healthcare Co Ltd 眠気が改善された感冒薬
JP6307874B2 (ja) * 2012-12-27 2018-04-11 大正製薬株式会社 レイヤリング粒子
JP7419057B2 (ja) * 2019-12-27 2024-01-22 ライオン株式会社 錠剤及びコーティング錠

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS609752B2 (ja) * 1979-11-09 1985-03-12 東邦新薬株式会社 新規な２−アセトキシベンズアミド誘導体、その製法及びそれを有効成分とする医薬
JPS5697224A (en) * 1979-12-28 1981-08-05 Kaken Pharmaceut Co Ltd Antipyretic analgesic composition
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
JPS61134315A (ja) * 1984-12-05 1986-06-21 Taisho Pharmaceut Co Ltd 解熱鎮痛剤
GB8623557D0 (en) * 1986-10-01 1986-11-05 Boots Co Plc Therapeutic agents
US4999226A (en) * 1988-06-01 1991-03-12 Merrell Dow Pharmaceuticals Inc. Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination
US5368861A (en) * 1989-10-26 1994-11-29 Nippon Shinyaku Co., Ltd. Gastric preparation with sustained release
US5213807A (en) * 1990-05-03 1993-05-25 Chemburkar Pramod B Pharmaceutical composition containing ibuprofen and a prostaglandin
EP0580861B1 (de) * 1991-04-08 1998-09-09 Nippon Shinyaku Company, Limited Kapsel mit Langzeitwirkung fuer die Adhäsion im Gastrointestinaltrakt
US5431916A (en) * 1993-04-29 1995-07-11 The Procter & Gamble Company Pharmaceutical compositions and process of manufacture thereof

Also Published As

Publication number Publication date
EP0812589A1 (de) 1997-12-17
TW279799B (de) 1996-07-01
DK0812589T3 (da) 2000-11-13
ES2148470T3 (es) 2000-10-16
CN1142766A (zh) 1997-02-12
KR100347631B1 (ko) 2002-11-29
PT812589E (pt) 2000-11-30
WO1995015751A1 (fr) 1995-06-15
JP3168582B2 (ja) 2001-05-21
EP0812589B1 (de) 2000-08-16
US5686109A (en) 1997-11-11
EP0812589A4 (de) 1999-06-23
CN1094756C (zh) 2002-11-27
KR960706335A (ko) 1996-12-09
ATE195418T1 (de) 2000-09-15
GR3034434T3 (en) 2000-12-29
DE69425589T2 (de) 2001-01-04

Similar Documents

Publication Publication Date Title
DE69425589D1 (de) Kombiniertes antipyretisches und analgetisches arzneimittel
ATE216220T1 (de) Osmotische darreichungsform mit zwei mantelschichten
CA2182508A1 (en) Abuse resistant tablets
RU93058536A (ru) Орально вводимая форма лекарственного средства на основе пантопразола
ITMI922192A1 (it) Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
SE9600070D0 (sv) New oral pharmaceutical dosage forms
CA2214033A1 (en) Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a prokinetic agent
DE69832816D1 (de) Orale pharmazeutische dosierungsform mit verlängerter wirkstofffreisetzung
DE69327490D1 (de) Arzneimittel aus Polymer-Micellen mit physikalischer Einschlusswirkung
ES2161288T3 (es) Comprimido revestido con polimero que comprende amoxicilina y clavulanato.
DK0760655T3 (da) Farmaceutisk flerlags doseringsform med reguleret frigivelse
DE69323442D1 (de) Flüssige pharmazeutische Formulierung mit verlängerter Wirkstoffabgabe
ID26340A (id) Kapsul ganda dengan penggunaan bahan-bahan aktif dalam berbagai macam pengobatan
AR004486A1 (es) Uso de tripicolinato cromico en la preparacion de un medicamento
ATE290855T1 (de) Laminare arzneiform
ATE101039T1 (de) Oral anzuwendende arzneimittel in einzeldosisform.
KR920019365A (ko) 디리트로마이신을 함유하는 약학 제형
IT1196190B (it) Forma farmaceutica solida orale ad azione sequenziale per la somministrazione di farmaci ad effetto collaterale ulcerogeno
DE69914472D1 (de) Levosimendanhaltige oral anzuwendende arzneimittel mit gesteuerter wirkstoffverabreichung
TR199901237T2 (xx) Bir tienilsiklohegzilamin t�revinin tedavide yeni uygulamas�.
KR920019369A (ko) 위장병에 유용한 제약학적 복합 성분물
ATE157360T1 (de) Thienocyclopentanonoximether, ihre herstellung und diese enthaltende arzneimittel
TH24054A (th) ผลิตภัณฑ์กระดาษแผ่นเยื่อที่มีสารยา
ITRM910432A0 (it) Dispositivo per l'applicazione endo ed esoretale di sostanze farmacologoche, medicamentose e rinfrescanti.
ITMI940030A0 (it) Compressa farmaceutica ad eleavata e rapida disponibilita' del principio attivo in essa veicolato

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee